Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effectiveness and safety of Setidegrasib in combination with either modified FOLFIRINOX (mFOLFIRINOX) or the Nal-IRI-based…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• NALIRIFOX (liposomal irinotecan + 5-fluorouracil/leucovorin)
• Setidegrasib (setidegrasib)
• modified FOLFIRINOX (mFOLFIRINOX)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 3 | Status: RECRUITING